España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
InMode
INMD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.79
0.22
1.33%
At close: -
$16.79
0.00
0.00%
After Hours: Jan 17, 4:00 PM EDT
Get Report
Comment
InMode (INMD) Forecast
News
Earnings
InMode (INMD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for InMode (NASDAQ:INMD) Stock
InMode Stock (NASDAQ: INMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, January 15, 2025
InMode Shareholder DOMA Perpetual Sends Lette...
Benzinga Newsdesk
Thursday, January 09, 2025
Barclays Maintains Overweight on InMode, Lowe...
Benzinga Newsdesk
Wednesday, January 08, 2025
InMode shares are trading lower after the com...
Benzinga Newsdesk
InMode Expects Full-Year 2025 Revenue Of $395...
Benzinga Newsdesk
InMode Cuts FY24 Revenue Outlook From $410M -...
Benzinga Newsdesk
InMode Expects Q4 Revenue Of $97.0M-$97.5M (E...
Benzinga Newsdesk
Tuesday, November 26, 2024
Under the Radar: From Overlooked to Overperforming - Global Markets Await
Tim Melvin
Thursday, October 31, 2024
Needham Reiterates Hold on InMode
Benzinga Newsdesk
Wednesday, October 30, 2024
InMode Cuts FY24 Revenue Outlook From $430M -...
Benzinga Newsdesk
InMode Q3 2024 Adj EPS $0.70 Beats $0.63 Esti...
Benzinga Newsdesk
Thursday, October 24, 2024
InMode Says It Is Granted Preliminary Injunct...
Benzinga Newsdesk
Thursday, October 17, 2024
This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
BTIG Initiates Coverage On InMode with Buy Ra...
Benzinga Newsdesk
Monday, October 14, 2024
Barclays Maintains Overweight on InMode, Lowe...
Benzinga Newsdesk
Thursday, October 10, 2024
Needham Reiterates Hold on InMode
Benzinga Newsdesk
InMode Expects Q3 Revenue Between $130M-$130....
Benzinga Newsdesk
Tuesday, September 10, 2024
InMode shares are trading higher after the co...
Benzinga Newsdesk
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
InMode Board Approves Share Repurchase Progra...
Benzinga Newsdesk
Tuesday, August 20, 2024
CORRECTTION: InMed Ticker Is 'INM'
Benzinga Newsdesk
Thursday, August 01, 2024
InMode shares are trading lower after the com...
Benzinga Newsdesk
InMode Q2 2024 Adj. EPS $0.46 Beats $0.38 Est...
Benzinga Newsdesk
Tuesday, July 23, 2024
Jefferies Downgrades InMode to Hold, Lowers P...
Benzinga Newsdesk
Wednesday, July 17, 2024
InMode Announces Morpheus8 FDA 510(k) Clearan...
Benzinga Newsdesk
Monday, July 15, 2024
Barclays Maintains Overweight on InMode, Lowe...
Benzinga Newsdesk
Friday, July 12, 2024
Canaccord Genuity Maintains Hold on InMode, L...
Benzinga Newsdesk
Thursday, July 11, 2024
Needham Reiterates Hold on InMode
Benzinga Newsdesk
InMode Sees Q2 Revenue Between $86.2M-$86.3M,...
Benzinga Newsdesk
Friday, May 03, 2024
Needham Reiterates Hold on InMode
Benzinga Newsdesk
Thursday, May 02, 2024
InMode Sees FY24 Adj EPS OF $2.01 - $2.05 Vs....
Benzinga Newsdesk
InMode Cuts FY24 Revenue Guidance From $495M ...
Benzinga Newsdesk
InMode Q1 Adj $0.32 Misses $0.44 Estimate, Sa...
Benzinga Newsdesk
Monday, April 15, 2024
InMode Defends Its Feminine Rejuvenation Pate...
Benzinga Newsdesk
Friday, April 12, 2024
Barclays Maintains Overweight on InMode, Lowe...
Benzinga Newsdesk
Thursday, April 11, 2024
BTL Petitions USPTO To Cancel All 58 Claims O...
Benzinga Newsdesk
Tuesday, April 09, 2024
Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Needham Reiterates Hold on InMode
Benzinga Newsdesk
Maxeon Solar Technologies, Neogen And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Wednesday, April 03, 2024
CORRECTION: OneMedNet Ticker Is 'ONMD'
Benzinga Newsdesk
Monday, March 11, 2024
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Monday, February 26, 2024
5 Value Stocks In The Healthcare Sector
Benzinga Insights
Tuesday, February 20, 2024
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Tuesday, February 13, 2024
InMode shares are trading lower after the com...
Benzinga Newsdesk
InMode Expects FY24 Revenue Of $495M-$505M (V...
Benzinga Newsdesk
InMode Q4 Adj. EPS $0.71 Beats $0.67 Estimate...
Benzinga Newsdesk
Earnings Scheduled For February 13, 2024
Benzinga Insights
Monday, February 12, 2024
InMode's Earnings: A Preview
Benzinga Insights
Thursday, January 18, 2024
Barclays Maintains Overweight on InMode, Lowe...
Benzinga Newsdesk
Thursday, January 04, 2024
Barclays Maintains Overweight on InMode, Lowe...
Benzinga Newsdesk
Thursday, December 07, 2023
Canaccord Genuity Reiterates Hold on InMode, ...
Benzinga Newsdesk
Show More
